Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
Condition: Breast Cancer Interventions: Drug: Letrozole; Drug: Palbociclib; Drug: Goserelin; Diagnostic Test: Oncotype DX Breast Recurrence Score Sponsors: NSABP Foundation Inc; Genomic Health®, Inc.; Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Neoadjuvant Therapy | Ovarian Cancer | Ovaries | Pfizer | Research